0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
India’s pharma exports may double to $65B by 2030 despite US tariff threats, driven by complex generics, innovation, and stronger global regulatory alignment.
Share this article
If you liked this article share it with your friends.they will thank you later